The Future of Cancer Care

Fox-KTVU
26 followers
6 Video Views·Jul 14, 2026
AI Generated·May contain errors
Video Summary
AI GeneratedDr. Shane Dormady discusses the evolution of cancer care, emphasizing that targeted therapies and molecular profiling are transforming cancer from a potential death sentence into a manageable medical condition. By analyzing the genetic mutations of tumors, doctors can now provide personalized treatments that significantly extend the lives of patients, even those with stage 4 cancer.
All right, to some health news here. According to the American Cancer Society,
there will be 2.1 million new cancer cases diagnosed in the United States this year.
Some 626,000 people are expected to die of cancer, but doctors want everyone to know
the same type of cancer can act very differently in each person. And now there's new hope for what
some call the future of cancer care, targeted therapies. I'm so happy to welcome to Mornings
On 2, Dr. Shane Dormady. He's the Acampo Family Medical Director of Oncology at El Camino Health.
Thanks for being with us, doctor.
Thank you for having me.
It was not that long ago that cancer was pretty much a death sentence,
and you're telling us now that even someone diagnosed with a stage 3 or 4 cancer has hope?
Absolutely. I think what we're starting to realize is that someone's prognosis and the
treatment for the cancers isn't so much related to the anatomic region of the body where the
cancer develops, but it's more we're unlocking the DNA, the code that goes awry with cancer cells
and allows them to grow and divide uncontrollably. But these cancer cells end up developing certain
genetic anomalies or mutations that can often be targeted directly by our new therapies.
So essentially a breast cancer in me might act differently than in my sister-in-law,
than in my neighbor?
Absolutely. Cancers can behave aggressively. They can behave indolently.
What's indolently?
Indolent means nice cancer. Very slow growing, slowly progressive, and slow to metastasize.
How do you figure out what kind each person has?
Well, basically there are assays you can do now. It's even come down to just drawing a tube of
blood where we can analyze tumor cell DNA circulating in the bloodstream to find these
little mutations and then target them. You can also do a similar type of assay on
biopsy specimens from the tumor themselves.
Okay, let's go back to breast cancer because it's one of the most common and because I
just found out a family friend was diagnosed. It's interesting because my level of panic
was not sky high and I attribute that to some of the medical advancements that have been made,
but also the changing conversation about breast cancer and the fact that we're seeing
so many women get it and so many women live with it and through it.
Oh, absolutely. I mean, depending on the fingerprint of the breast cancer cells,
breast cancer cells can be targeted with hormonal therapies. They can be targeted
with certain chemotherapies and they can be targeted with molecular types of treatments
that home in on proteins on the surface of the cancer cell. A particular protein called HER2
is very targetable and we have a variety of new medicines to target that protein.
It does seem like we are hearing more and more about people being diagnosed with cancer.
The numbers are rising. How should we view cancer today?
I think today what should be stressed is that, and I tell all my patients this,
cancer is a medical condition. I tell my patients don't get caught up in stage three,
stage four. I'm going to lose my hair. I need a mastectomy.
Those things are an unfortunate reality sometimes, but in terms of living and dying,
I tell patients don't think of this as a death sentence. Even with stage four disease
in this day and age, if you do the molecular profiling, if you find the weaknesses in the
cancer cells on a genetic level, patients with stage four disease can have their medical condition,
the cancer controlled, just like high blood pressure or diabetes, indefinitely. So patients
with stage four disease, who 20, 30 years ago were living three to six months, are now living
five years, 10 years, 15 years and beyond. And so what do you say to people who say,
I don't want to go in for my annual, I don't know what's going on in there?
Well, I sympathize. I think none of us want to get bad news, but at the same time,
the key with cancer is to catch it early. So screening studies like mammograms, pap smears,
colonoscopies are critical to catch the cancer at an early stage and save lives.
I've reframed it as I have to, to, I get to, I joke. I'm in my insurance era.
It's your privilege.
It is my privilege. Absolutely. Thank you so much, doctor. It's so nice to connect.
Dr. Shane Dormady, the Ocampo Family Medical Director of Oncology. Thank you so much.
Thank you.
Thank you. And we will be right back.
